SCHEMBL25842179

SCHEMBL25842179

CC(C)=CCc1ccc(C)c2[nH]cc(CC(C)N)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS2 Q07890 1/20 0.49
HTR2A P28223 7/20 0.38
HTR2C P28335 7/20 0.38
HTR2B P41595 5/20 0.37
HTR1A P08908 4/20 0.37
HTR1D P28221 3/20 0.37
HTR1B P28222 3/20 0.37
HTR6 P50406 3/20 0.37
ADRA2A P08913 2/20 0.37
HTR7 P34969 2/20 0.37
ADRB1 P08588 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR1E P28566 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
NFKB1 P19838 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25842370 0.85 TNF (0.42) SOS2HTR2AHTR2CHTR2BHTR1A
SCHEMBL25842226 0.84 KDM4E (0.42) SOS2CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL25305253 0.82 HTR2A (0.47) HTR2AHTR2CHTR2BHTR1AHTR1D
SCHEMBL25842177 0.80 CYP19A1 (0.35) HTR2ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL26202347 0.77 HTR2A (0.49) HTR2AHTR2CHTR2BHTR1AHTR1D
SCHEMBL25842174 0.74 SOS2 (0.46) SOS2HTR2AHTR2CHTR2BHTR1A
SCHEMBL26202248 0.71 HTR2A (0.47) HTR2AHTR2CHTR2BHTR1AHTR1D
SCHEMBL20552171 0.68 TNF (0.47) SOS2HTR2AHTR2CHTR2BHTR1A
SCHEMBL25382101 0.68 KDM4E (0.44) HTR2AHTR2CHTR2BHTR1AHTR7
SCHEMBL26202498 0.68 HTR2A (0.44) HTR2AHTR2CHTR2BHTR1AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219888-A1 PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING MAGICMED INDUSTRIES INC. (CA) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219888-A1 PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING AANAT, ACAT2, PCYT1A SOS2 3327/4885HTR2A 1566/4885HTR2C 1158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.